amlodipine has been researched along with Arteriosclerosis Obliterans in 2 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Arteriosclerosis Obliterans: Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim: To analyze the dynamics of daily monitoring of blood pressure, intracardiac (according to echocardiography), peripheral hemodynamics (according to ultrasound of the vessels of the lower extremity), the thickness of the intima-media complex (according to carotid sonography) in patients with hypertension the effect of treatment with a combination of lisinopril and amlodipine." | 8.12 | EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE. ( Babinets, LS; Halabitska, IM; Kryskiv, OI; Levchuk, RD, 2022) |
| "The aim: To analyze the dynamics of daily monitoring of blood pressure, intracardiac (according to echocardiography), peripheral hemodynamics (according to ultrasound of the vessels of the lower extremity), the thickness of the intima-media complex (according to carotid sonography) in patients with hypertension the effect of treatment with a combination of lisinopril and amlodipine." | 4.12 | EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE. ( Babinets, LS; Halabitska, IM; Kryskiv, OI; Levchuk, RD, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babinets, LS | 2 |
| Levchuk, RD | 2 |
| Halabitska, IM | 2 |
| Kryskiv, OI | 2 |
| Okuro, M | 1 |
| Morimoto, S | 1 |
| Takahashi, T | 1 |
| Okaishi, K | 1 |
| Nakahashi, T | 1 |
| Murai, H | 1 |
| Iwai, K | 1 |
| Kanda, T | 1 |
| Matsumoto, M | 1 |
1 trial available for amlodipine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
Angiotensin I-converting enzyme inhibitor improves reactive hyperemia in elderly hypertensives with arteriosclerosis obliterans.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis Obli | 2006 |
1 other study available for amlodipine and Arteriosclerosis Obliterans
| Article | Year |
|---|---|
EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.
Topics: Amlodipine; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Pressure; Comorbidity; Gener | 2022 |
EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.
Topics: Amlodipine; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Pressure; Comorbidity; Gener | 2022 |
EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.
Topics: Amlodipine; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Pressure; Comorbidity; Gener | 2022 |
EFFECTIVENESS OF LISINOPRIL AND AMLODIPINE COMBINATION AT HYPERTENSION WITH COMORBIDITY OF ARTERIOSCLEROSIS OBLITERANS IN GENERAL PRACTICE.
Topics: Amlodipine; Antihypertensive Agents; Arteriosclerosis Obliterans; Blood Pressure; Comorbidity; Gener | 2022 |